Literature DB >> 20233852

International efforts to develop biospecimen best practices.

Jimmie B Vaught1, Elodie Caboux, Pierre Hainaut.   

Abstract

Variables introduced during the processes involved in biospecimen collection, processing, storage, and analysis are among the potential sources of bias in biomarker research. International efforts are under way to develop best practices to standardize biospecimen handling protocols. In general, documents on best practices address three major recurring themes: technical best practices on infrastructure and specimen handling, recommendations on informatics and data management, and recommendations on ethical, legal, and social issues. There are many areas of agreement among various international efforts, but no single set of practices has emerged as a unifying document. The ethical, legal, and social issues are particularly difficult to harmonize due to the many country-specific issues that are governed by a variety of local and federal rules and regulations. Given the increasingly international nature of research involving biomarkers and biospecimens, it will be necessary to continue to cooperate in the development of harmonized evidence-based best practices. Several international organizations including the International Cancer Genome Consortium are engaged in such efforts.

Mesh:

Substances:

Year:  2010        PMID: 20233852     DOI: 10.1158/1055-9965.EPI-10-0058

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  18 in total

1.  Issues in data management.

Authors:  Margi Joshi; Sharon S Krag
Journal:  Sci Eng Ethics       Date:  2010-07-06       Impact factor: 3.525

2.  Biospecimens and biorepositories: from afterthought to science.

Authors:  Jimmie B Vaught; Marianne K Henderson; Carolyn C Compton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-02       Impact factor: 4.254

3.  Biobanking and international interoperability: samples.

Authors:  Michael Kiehntopf; Michael Krawczak
Journal:  Hum Genet       Date:  2011-07-15       Impact factor: 4.132

4.  Pediatric diabetes registries: when baby steps are not enough.

Authors:  Chad Malone; Gary D Kennedy
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

5.  A primer on a hepatocellular carcinoma bioresource bank using the cancer genome atlas guidelines: practical issues and pitfalls.

Authors:  N Thao T Nguyen; Ron T Cotton; Theresa R Harring; Jacfranz J Guiteau; Marie-Claude Gingras; David A Wheeler; Christine A O'Mahony; Richard A Gibbs; F Charles Brunicardi; John A Goss
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

Review 6.  Current state of the art for enhancing urine biomarker discovery.

Authors:  Michael Harpole; Justin Davis; Virginia Espina
Journal:  Expert Rev Proteomics       Date:  2016-06       Impact factor: 3.940

7.  Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.

Authors:  Sheri D Schully; Danielle M Carrick; Leah E Mechanic; Sudhir Srivastava; Garnet L Anderson; John A Baron; Christine D Berg; Jennifer Cullen; Eleftherios P Diamandis; V Paul Doria-Rose; Katrina A B Goddard; Susan E Hankinson; Lawrence H Kushi; Eric B Larson; Lisa M McShane; Richard L Schilsky; Steven Shak; Steven J Skates; Nicole Urban; Barnett S Kramer; Muin J Khoury; David F Ransohoff
Journal:  J Natl Cancer Inst       Date:  2015-02-16       Impact factor: 13.506

8.  International approaches to advancing biospecimen science.

Authors:  Helen M Moore; Carolyn C Compton; Joseph Alper; Jimmie B Vaught
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-03-23       Impact factor: 4.254

Review 9.  The evolution of biobanking best practices.

Authors:  Jim Vaught; Nicole C Lockhart
Journal:  Clin Chim Acta       Date:  2012-05-03       Impact factor: 3.786

10.  Toward a roadmap in global biobanking for health.

Authors:  Jennifer R Harris; Paul Burton; Bartha Maria Knoppers; Klaus Lindpaintner; Marianna Bledsoe; Anthony J Brookes; Isabelle Budin-Ljøsne; Rex Chisholm; David Cox; Mylène Deschênes; Isabel Fortier; Pierre Hainaut; Robert Hewitt; Jane Kaye; Jan-Eric Litton; Andres Metspalu; Bill Ollier; Lyle J Palmer; Aarno Palotie; Markus Pasterk; Markus Perola; Peter H J Riegman; Gert-Jan van Ommen; Martin Yuille; Kurt Zatloukal
Journal:  Eur J Hum Genet       Date:  2012-06-20       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.